Methotrexate treatment and mortality in rheumatoid arthritis.
作者信息
Tröger Uwe, Bode-Böger Stefanie M
出版信息
Lancet. 2002 Oct 5;360(9339):1096; author reply 1097-8. doi: 10.1016/S0140-6736(02)11158-5.
Abstract
摘要
相似文献
1
Methotrexate treatment and mortality in rheumatoid arthritis.甲氨蝶呤治疗与类风湿关节炎的死亡率
Lancet. 2002 Oct 5;360(9339):1096; author reply 1097-8. doi: 10.1016/S0140-6736(02)11158-5.
2
Methotrexate treatment and mortality in rheumatoid arthritis.甲氨蝶呤治疗与类风湿关节炎死亡率
Lancet. 2002 Oct 5;360(9339):1095; author reply 1097-8. doi: 10.1016/S0140-6736(02)11156-1.
3
Methotrexate treatment and mortality in rheumatoid arthritis.甲氨蝶呤治疗与类风湿关节炎死亡率
Lancet. 2002 Oct 5;360(9339):1095-6; author reply 1097-8. doi: 10.1016/S0140-6736(02)11157-3.
4
[Methotrexate and non-steroidal anti-inflammatory agent combination in rheumatoid arthritis].甲氨蝶呤与非甾体抗炎药联合治疗类风湿关节炎
Therapie. 1997 Mar-Apr;52(2):133-7.
5
Etanercept in rheumatoid arthritis.类风湿关节炎中的依那西普。
N Engl J Med. 1999 Jun 24;340(25):2000; author reply 2001. doi: 10.1056/NEJM199906243402512.
6
[Advances in the drug therapy of rheumatoid arthritis].
Zhonghua Nei Ke Za Zhi. 1997 Apr;36(4):273-5.
7
Etanercept in rheumatoid arthritis.
N Engl J Med. 1999 Jun 24;340(25):2000-1.
8
Cardiovascular disease in rheumatoid arthritis: disease and treatment interactions and their implications on treatment decisions.类风湿关节炎中的心血管疾病：疾病与治疗的相互作用及其对治疗决策的影响
J Miss State Med Assoc. 2010 Mar;51(3):75-80.
9
[Excess mortality from cardiovascular disease in patients with rheumatoid arthritis--NSAID a possible cause?].[类风湿关节炎患者心血管疾病的超额死亡率——非甾体抗炎药可能是一个原因？]
Ugeskr Laeger. 2011 Mar 14;173(11):837; author reply 837.
10
Predictors of response to methotrexate in early DMARD naive rheumatoid arthritis: results from the initial open-label phase of the SWEFOT trial.早期甲氨蝶呤初治类风湿关节炎患者对甲氨蝶呤应答的预测因素：来自 SWEFOT 试验初始开放性标签阶段的结果。
Ann Rheum Dis. 2011 Mar;70(3):469-75. doi: 10.1136/ard.2010.139212. Epub 2010 Dec 13.
Zotero 插件